Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Winthrop-University Hospital, Mineola, New York, USA. sfishbane@metrorenal.com
Anemia is common in chronic kidney disease (CKD). The CHOIR study found increased risk of a composite cardiovascular outcome when anemia was treated with epoetin-alfa to a target hemoglobin level of 13.5 as compared with 11.3 g/dl. Whether this increase applies to all patient subgroups equally is unclear. We discuss an analysis by Szczech and colleagues of the effects of the higher hemoglobin target in CKD patients with diabetes mellitus or congestive heart failure.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on